Diurnal Vessel Density Changes Not Linked to IOP

OCT-A debunks this common theory in glaucoma care.

DR, AMD and Glaucoma all Classified with AI

New studies show promise for detecting many ocular conditions with deep learning.

Sustained Glaucoma Treatment Acceptable, Patients Say

…but only if it eliminates surgery or works better than drops.

Monitoring Glaucoma in KPro Patients

Research suggests overcoming hurdles to monitoring is crucial.

Glaucoma Treatment While You Sleep

News for 4/20: a drug delivery system using a cannabis compound shows promise.

Hope For Noninvasive ICP Monitoring

Often overlooked, the "other" pressure at play in glaucoma is finally getting its due.

The Devil is in the Details

When a glaucoma suspect progresses, it’s time to transition from monitoring to treating. But what happens when devices differ?

The MIGS Just Keep on Coming

Two new devices expand the treatment portfolio and target novel pathways.

OCT-A Compares Glaucoma, Myopic Damage

Impaired blood flow is worse in open-angle patients than in myopes.

Novel Detection of Early Glaucoma Shows Promise

Quantifying retinal nerve fiber bundle abnormality in the temporal raphe may uncover changes sooner.

Upcoming Events

April 26-28, 2018

New Technologies & Treatments in Eye Care San Diego
Location: San Diego Marriott Del Mar
Program Chair: Paul Karpecki, OD, FAAO
Up to 19 CE credits (COPE approval pending)
Register Here

April 28-29, 2018

OCCRS 15th Annual Symposium
Location: San Diego Marriott Del Mar
Program Chair: David Friess, OD, FAAO
Up to 10 CE credits (COPE approval pending)
Register here

May 5, 2018

Pathways for Achieving Premium Outcomes
Location: Philadelphia Marriott West
Program Chairs: Sondra Black, OD, and Douglas Devries, OD
Up to 3 CE credits (COPE approval pending)
Register here


Jobs Powered By Local Eye Site